Connect
MJA
MJA

Policy considerations for mandatory COVID-19 vaccination from the Collaboration on Social Science in Immunisation

Julie Leask, Holly Seale, Jane H Williams, Jessica Kaufman, Kerrie Wiley, Abela Mahimbo, Katrina K Clark, Margie H Danchin and Katie Attwell
Med J Aust
Published online: 13 September 2021

This article was published as a peer-reviewed Accepted Article (prior to structural editing and typesetting) on 13 September 2021. The final version of record can be found at: https://www.mja.com.au/journal/2021/215/11/policy-considerations-mandatory-covid-19-vaccination-collaboration-social

  • Julie Leask1
  • Holly Seale2
  • Jane H Williams1
  • Jessica Kaufman2
  • Kerrie Wiley1
  • Abela Mahimbo4
  • Katrina K Clark5
  • Margie H Danchin3,6
  • Katie Attwell7

  • 1 University of Sydney
  • 2 University of New South Wales
  • 3 Murdoch Children’s Research Institute
  • 4 University of Technology, Sydney
  • 5 The Children's Hospital at Westmead
  • 6 Royal Children's Hospital
  • 7 The University of Western Australia


Correspondence: julie.leask@sydney.edu.au

Competing interests:

Disclosures:

Julie Leask and Kerrie Wiley have received a grant from NHMRC to study policy aspects of childhood vaccine refusal.

Holly Seale has previously received funding for investigator driven research from NSW Ministry of Health, as well as from Sanofi Pasteur and Seqirus (not related to this project).

Julie Leask sits on the Expert Advisory Group for the Victorian Department of Health and Human Services and was a temporary unpaid advisor to the Vaxzevria (previously COVID-19 Vaccine AstraZeneca) Advisory Board.

Jessica Kaufman and Margie Danchin’s institution MCRI receives funding from the Commonwealth and Victorian Department of health for COVID-19 vaccine social research.

Katie Attwell is a current recipient of a Discovery Early Career Researcher Award funded by the Australian Research Council of the Australian Government (DE19000158) focusing on mandatory vaccination.

Katie Attwell receives funding to her institution from the Western Australia Department of Health for COVID-19 vaccine social research (Coronavax). Coronavax is also funded through a Wesfarmers Centre of Vaccines and Infectious Diseases Catalyst grant, and a Future Health Research & Innovation Fund COVID-19 Focus Grant.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.